Total Funding
83
15
Total FundingVenture - Series Unknown raised
Growth Score 83 in past quarter
-1 pts
Heat Score 15 in past quarter
-22 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
57690
PlasmaGen Biosciences develops and distributes a range of blood plasma-derived therapeutic products used by healthcare providers.
- Vinod Nahar: Director & Founder
- Ranjeet S. Ajmani: Chief Executive OfficerPast Role: Nirma University, Visiting Faculty : School of Pharmacy
About the Company
PlasmaGen Biosciences develops and distributes a range of blood plasma-derived therapeutic products used by healthcare providers. The company’s portfolio includes plasma protein therapies such as human albumin, various immunoglobulins, and specialty products used in conditions across haematology, immunology, oncology, and critical care. It manages
sourcing, processing, and handling of human plasma through licensed collection, cold-chain logistics, and manufacturing partnerships to produce finished pharmaceutical products. PlasmaGen also engages in partnership and distribution arrangements for additional plasma-based therapies across selected international markets.